Clinical Trials Sponsored by Miltenyi Biotec B.V. & Co. KG

Total 12 results

Miltenyi Biotec B.V. & Co. KG

Completed

Proof of Concept Study of IMMUNOadsorption Therapy in Patients With Idiopathic Pulmonary Arterial Hypertension

Idiopathic Pulmonary Arterial Hypertension

Germany
M.D. Anderson Cancer Center
Miltenyi Biotec B.V. & Co. KG

Completed

Autologous Cytomegalovirus (CMV)-Specific Cytotoxic T Cells for Cytomegalovirus (CMV) Reactivation

Lymphoma | Leukemia

United States
Yae-Jean Kim
Miltenyi Biotec B.V. & Co. KG

Withdrawn

Adoptive Transfer of pp65-specific T Cells for the Treatment of Refractory Cytomegalovirus (CMV) Infection

Cytomegalovirus Infections

Korea, Republic of
Miltenyi Biotec B.V. & Co. KG
German Federal Ministry of Education and Research

Terminated

Intramyocardial Transplantation of Bone Marrow Stem Cells in Addition to Coronary Artery Bypass Graft (CABG) Surgery (PERFECT)

Myocardial Ischemia | Coronary Artery Disease

Germany
Miltenyi Biotec B.V. & Co. KG
University of Chicago; Ohio State University; Masonic Cancer Center, University...

Terminated

CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploidentical Donor Natural Killer (NK) Cell Based Therapy for AML Patients Not in CR

Acute Myelogenous Leukemia

United States
Wissenschaftliches Institut Bethanien e.V
Löwenstein Medical Technology GmbH & Co. KG

Terminated

Influence of an Inverse Pressure Ramp in Long-term Non-invasive Ventilation on Dyspnea in the Morning After Therapy

Dyspnea | Noninvasive Ventilation

Germany
Swiss Tropical & Public Health Institute
Ifakara Health Institute; Sumaya Biotech GmbH & Co. KG

Completed

Assessment of the Malaria Vaccine Candidate SumayaVac-1 in Healthy Adults Aged 18-45 Years Living in a Malaria Endemic Country (SUM-101)

Malaria

Tanzania
Universitätsklinikum Hamburg-Eppendorf
Neovii Biotech; Clinical Trial Center North (CTC North GmbH & Co. KG)

Terminated

Ocrelizumab or Alemtuzumab Compared With Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis - a Phase-2 Randomised Controlled Trial (COAST)

Relapsing-Remitting Multiple Sclerosis

Germany
Pharming Technologies B.V.
Laboratory Corporation of America; CMIC Co, Ltd. Japan; Axial Biotech, Inc

Recruiting

An Open-Label Study to Assess the Safety & Efficacy of Leniolisib in Japanese Patients With APDS

APDS Gene Mutation

Japan
University Hospital Muenster
Deutsche Krebshilfe e.V., Bonn (Germany); photonamic GmbH & Co. KG; medac GmbH; LifePhotonic GmbH

Recruiting

Stereotactical Photodynamic Therapy With 5-aminolevulinic Acid (Gliolan®) in Recurrent Glioblastoma (NOA11)

Glioblastoma Multiforme, Adult

Germany
ConvaTec Inc.
ClinSearch; Welsh Wound Innovation Centre; Qualizyme Diagnostics GmbH & Co KG; Perfectus... and other collaborators

Withdrawn

Analytical Performance of pH, HNE and MPO Levels in Detecting Wound Infection Proof of Concept Biomarker Study (INDICATE)

Wound Infection | Wound Heal
Prof. Tobias Feuchtinger
European Commission; Simbec-Orion Group Ltd, Merthyr Tydfil, UK; Miltenyi Biotec... and other collaborators

Recruiting

Multivirus-specific T-cell Transfer Post SCT vs AdV, CMV and EBV Infections (TRACE)

CMV Infection | EBV Infection | Stem Cell Transplant Complications | AdV Infection

Belgium, Spain, France, Germany, Italy, Netherlands

Clinical Trials Sponsored by Miltenyi Biotec B.V. & Co. KG

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Armenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations